SEC 13F Intelligence

Armistice Capital, LLC / RI2

Armistice Capital, LLC’s Rigel Pharmaceuticals Inc Position

Does Armistice Capital, LLC own Rigel Pharmaceuticals Inc (RI2)? Yes — 1.28M shares worth $35M (+0.62% of its 13F portfolio) as of Q1 2026, up from 836.0K shares the prior filed quarter.

Position Value
$35M
Q1 2026
Shares
1.28M
% of Portfolio
+0.62%
Quarters Held
8
currently held

Position History RI2

Reported value by quarter
Q2 ’24: $13MQ2 ’24Q3 ’24: $25MQ3 ’24Q4 ’24: $19MQ4 ’24Q1 ’25: $27MQ1 ’25Q2 ’25: $30MQ2 ’25Q3 ’25: $21MQ3 ’25Q4 ’25: $36MQ4 ’25Q1 ’26: $35MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.28M$35M+0.62%
Q4 2025836.0K$36M+0.43%
Q3 2025724.0K$21M+0.30%
Q2 20251.60M$30M+0.52%
Q1 20251.52M$27M+0.41%
Q4 20241.15M$19M+0.26%
Q3 20241.54M$25M+0.40%
Q2 20241.62M$13M+0.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Armistice Capital, LLC’s full portfolio or all institutional holders of RI2.